Home /
health Podcasts /
JAMA Editors' Summary /
Sublingual Dexmedetomidine for Agitation in Bipolar Disorder, SARS-CoV-2 Infection and Maternal Morbidity and Mortality, Neurological Outcome in Refractory Out-of-Hospital Cardiac Arrest, and more

$Sublingual Dexmedetomidine for Agitation in Bipolar Disorder, SARS-CoV-2 Infection and Maternal Morbidity and Mortality, Neurological Outcome in Refractory Out-of-Hospital Cardiac Arrest, and more episode artwork$

EPISODE · Feb 22, 2022 · 13 MIN

Sublingual Dexmedetomidine for Agitation in Bipolar Disorder, SARS-CoV-2 Infection and Maternal Morbidity and Mortality, Neurological Outcome in Refractory Out-of-Hospital Cardiac Arrest, and more

from JAMA Editors' Summary

Editor's Summary by Kristin Walter, MD, Associate Editor of JAMA, the Journal of the American Medical Association, for the February 22, 2022 issue.

Episode metadata supplied by the publisher feed · Published Feb 22, 2022

Embed this episode

Attribution link and audio player

Ready to play

Sublingual Dexmedetomidine for Agitation in Bipolar Disorder, SARS-CoV-2 Infection and Maternal Morbidity and Mortality, Neurological Outcome in Refractory Out-of-Hospital Cardiac Arrest, and more

0:00 13:21

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of JAMA Editors' Summary?

This episode is 13 minutes long.

When was this JAMA Editors' Summary episode published?

This episode was published on February 22, 2022.

Can I download this JAMA Editors' Summary episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!